Abstract:
A method is provided for marking a petroleum fuel or other carbonaceous fluid with a marker or tracer. The method may include introducing the marker into the fluid. The marker may be a substance that is extractable from a plant (including derivatives thereof and synthetically manufactured versions of such substances and derivatives). The plant may be a Cannabis plant and the marker may comprise cannabis oil or a cannabinoid. A detection method is further provided for detecting the presence of the marker in the fuel or other carbonaceous fluid. The detection method may comprise extracting the marker from the fluid into an aqueous layer, and analysing the aqueous layer for the presence of the marker. A marked carbonaceous product is also provided, comprising a carbonaceous fluid and a marker as described.
Abstract:
Provided here are compositions and methods for management of human papillomavirus-associated cancers. One such method of treating a human papillomavirus-associated cancer in a subject includes administering to the subject a therapeutically effective amount of gambogic acid or 30-hydroxygambogic acid or a pharmaceutically acceptable derivative thereof. These methods can also include administering one or more of radiation or a chemotherapeutic agent.
Abstract:
A presente invenção descreve compostos, o uso de compostos na preparação de uma composição farmacêutica e uma composição farmacêutica compreendendo os compostos conforme fórmula A, seus derivados ou análogos, neutros ou ionizados, para prevenção e/ou terapia senolítica. Especificamente, a presente invenção compreende os compostos de fórmula A, seus derivados ou análogos, neutros ou ionizados, para prevenção e/ou terapia senolítica, por meio de eliminação seletiva de células senescentes.
Abstract:
The present invention relates to an improved process for the separation of gallated epicatechins (EGCG & ECG) from green tea extract or green tea dust. The present invention specifically relates to an improved process for the separation of gallated epicatechins (EGCG & ECG) from green tea extract or green tea dust by forming hydrated gallated epicatechins (EGCG & ECG)-isonicotinic acid complex using isonicotinic acid as acid, organic solvents for liberating gallated epicatechins. The present invention more specifically relates to the process for the separation of gallated epicatechins (EGCG & ECG) from green tea extract or green tea dust, wherein processes comprises steps of dissolving, concentrating by centrifugation, adding, precipitating, filtering, slurrying, removing supernatant liquid, washing, extracting and freeze drying. The present invention also relates to hydrated gallated epicatechins (EGCG &ECG)-isonicotinic acid complex.
Abstract:
Methods of treating a viral infection in a subject are provided. The methods include administering a therapeutically effective amount of a pharmaceutical composition comprising ginkgolic acid (GA) to the subject in need thereof, where the virus comprises an enveloped virus. Further provided are specific viral infections that can be treated using the methods.
Abstract:
A method for the bio-enzymatic synthesis of tetrahydrocannabivarin (THC-v), cannabivarin (CBV) and cannabinol (CBN) by contacting a compound according to Formula I with a cannabinoid synthase enzyme. The cannabinoids are produced in the presence of a solvent in a bioreactor equipped with a controller.
Abstract:
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung, Gewinnung und Anreicherung von Cannabidiol und Verwendung. Die Erfindung betrifft ferner einen Cannabidiol-Extrakt und die Verwendung eines erhaltenen Cannabidiol-Extraktes in der Pharmazie und Kosmetik.
Abstract:
The present invention provides compounds of Formula I. Wherein Rl, L, and A are as described herein, or a pharmaceutical salt thereof, processes for preparing the compounds, and methods of treating a condition, such as hypertriglyceridemia, using the compounds.
Abstract:
Aqueous compositions comprising at least one hydrotrope and at least one active compound. The at least one hydrotrope is present in an amount: (a) effective to solubilize said at least one active compound in water; and/or (b) effective to increase transdermal penetration of said at least one active compound; and/or (c) effective to increase the bioavailability of said at least one active compound. The aqueous compositions are provided for cosmetic and other uses. Also provided are methods for preparing and using said compositions.